- Home
- TTOO vs CDIO Comparison
TTOO vs CDIO Comparison
Compare TTOO & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- CDIO
- Stock Information
- Founded
- TTOO 2006
- CDIO 2017
- Country
- TTOO United States
- CDIO United States
- Employees
- TTOO N/A
- CDIO N/A
- Industry
- TTOO Medical/Dental Instruments
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- TTOO Health Care
- CDIO Health Care
- Exchange
- TTOO Nasdaq
- CDIO Nasdaq
- Market Cap
- TTOO 10.7M
- CDIO 12.3M
- IPO Year
- TTOO 2014
- CDIO N/A
- Fundamental
- Price
- TTOO $0.27
- CDIO $0.53
- Analyst Decision
- TTOO Hold
- CDIO Buy
- Analyst Count
- TTOO 1
- CDIO 1
- Target Price
- TTOO $5.00
- CDIO $2.00
- AVG Volume (30 Days)
- TTOO 877.9K
- CDIO 2.5M
- Earning Date
- TTOO 02-13-2025
- CDIO 11-13-2024
- Dividend Yield
- TTOO N/A
- CDIO N/A
- EPS Growth
- TTOO N/A
- CDIO N/A
- EPS
- TTOO N/A
- CDIO N/A
- Revenue
- TTOO $7,677,000.00
- CDIO $35,688.00
- Revenue This Year
- TTOO $50.31
- CDIO $2,081.66
- Revenue Next Year
- TTOO $117.92
- CDIO $43.84
- P/E Ratio
- TTOO N/A
- CDIO N/A
- Revenue Growth
- TTOO N/A
- CDIO 180.90
- 52 Week Low
- TTOO $0.25
- CDIO $0.19
- 52 Week High
- TTOO $6.95
- CDIO $2.40
- Technical
- Relative Strength Index (RSI)
- TTOO 25.65
- CDIO 38.70
- Support Level
- TTOO $0.25
- CDIO $0.49
- Resistance Level
- TTOO $0.43
- CDIO $0.62
- Average True Range (ATR)
- TTOO 0.04
- CDIO 0.11
- MACD
- TTOO -0.00
- CDIO -0.06
- Stochastic Oscillator
- TTOO 7.80
- CDIO 8.34
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.